A Yorkshire-based company is quietly transforming how pharmaceutical and clinical waste is handled in the UK – and saving millions of tonnes of carbon along the way.

Waste management might not be the flashiest part of the pharmaceutical supply chain, but it’s one of the most impactful. Over the last decade, UK-based waste specialists BusinessWaste have helped divert more than 24 million wheelie bins of clinical waste from landfill – and saved the carbon equivalent of over 8.6 million trees in the process.

According to the firm’s latest figures, its operations have kept an estimated 3.6 million syringes and 1.4 million sharps containers out of landfill, alongside 650,000kg of expired or returned medicines. By treating and diverting these items into safer, lower-emission disposal streams, the company estimates it has helped reduce pharmaceutical emissions by over 90,000 tonnes of CO₂.

“We’ve been tackling clinical and pharmaceutical waste since day one – and what we’re seeing now is a huge shift in how seriously the industry is taking its environmental responsibilities,” said company spokesperson Mark Hall. “It’s not just about disposal anymore; it’s about traceability, transparency and carbon impact.”

As ESG commitments become embedded into procurement processes, BusinessWaste says its pharma clients are increasingly requesting auditable reporting on carbon savings, packaging circularity, and zero-to-landfill performance.

With the NHS alone producing over 133,000 tonnes of clinical waste annually, and pharmaceutical manufacturing responsible for more emissions than the automotive sector, the company believes the appetite for sustainable waste solutions will only grow.

“We’ve gone from being a niche player to an essential partner for hospitals, research labs and pharma manufacturers across the country,” added Hall. “People want ethical, clean waste handling – and they want proof.”

The company now ranks in the top 1% of Trustpilot-rated waste firms in the UK and plans to expand its clinical operations team to meet growing demand from life sciences clients.